Drug Surveillance Systems in Canada

Similar documents
Archived Content. Contenu archivé

Addressing the Harms of Prescription Drugs in Canada

Estimated Number and Percentage of Alcohol and Impairment- Related Crash Fatalities and Injuries, by Jurisdiction, Age and Population: Canada, 2009

Appearance before House of Commons Standing Committee on Health as part of its Study on the Government s Role in Addressing Prescription Drug Abuse

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Decriminalization of Personal Use of Psychoactive Substances

Estimating the volume of Contraband Sales of Tobacco in Canada

Physicians for a Smoke-Free Canada. A look at young adults and smoking Findings from the Canadian Tobacco Use Monitoring Survey

Recent trends in medical cannabis use in Canada

Canadian Addiction Survey (CAS)

Review of Controlled Drugs and Substances Act

Sampling Methodology

Decriminalization of Personal Use of Psychoactive Substances

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

Organ Donation and Transplantation in Canada

Prevalence of cannabis-impaired driving and crash risk

PROFILE AND PROJECTION OF DRUG OFFENCES IN CANADA. By Kwing Hung, Ph.D. Nathalie L. Quann, M.A.

Impaired Driving in Canada

What is Drug Trends? funded by the Australian Government under the Substance Misuse Prevention and Service Improvement Grants Fund

AN OVERVIEW OF FEDERAL DRUG-IMPAIRED DRIVING ENFORCEMENT AND PROVINCIAL LICENCE SUSPENSIONS IN CANADA

Marijuana and tobacco use among young adults in Canada: are they smoking what we think they are smoking?

Prince Edward Island: Preparation for Cannabis Legalization

Health Canada. Santé Canada. Tuberculosis in Canada pre-release

Canada s Low-Risk Alcohol Drinking Guidelines

Prevalence of past year substance use in British Columbia and other provinces of Canada from 2008 to 2012

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis

Prevalence of substance use in lifetime, past year and past 30 days in British Columbia and other provinces of Canada from 2008 to 2012 (2)

Tobacco Use in Canada: Patterns and Trends

Controlled Substances

Report from the National Diabetes Surveillance System:

Impaired driving statistics

Ontario s Narcotics Strategy

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch

Taking Stock of the 2009 PoA Research and Trend Analysis Branch

REPORT FROM THE CANADIAN CHRONIC DISEASE SURVEILLANCE SYSTEM: ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN CANADA, 2018

National Treatment Indicators Report, 2012

Toward a Policy-Relevant Typology of Cannabis Use for Canada

An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018

Cannabis Legalization and Regulation

The Canadian context for cannabis policy and public health approaches to substance use

Poison Control Centres

Physiotherapists in Canada, 2011 National and Jurisdictional Highlights

Appendix B Fracture incidence and costs by province

Article. Trends in teen sexual behaviour and condom use. by Michelle Rotermann. Component of Statistics Canada Catalogue no X Health Reports

$113 Vol 34, No 2-3, July 2014 Chronic Diseases and Injuries in Canada

Provincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Smoking Cessation and the Workplace

Alcohol Indicators Report Executive Summary

Mental Health Statistics, to

EMBARGOED NOT FOR RELEASE PRIOR TO AM WEDNESDAY OCTOBER

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

THE PRESENCE OF ALCOHOL AND/OR DRUGS IN MOTOR VEHICLE FATALITIES, BY JURISDICTION: CANADA, 2013 November 15, 2017

National Treatment Indicators Report

CHAPTER 4: Population-level interventions

In preparation : The impact of raising minimum alcohol prices in Saskatchewan, Canada: Improving public health while raising government revenue?

Drug-related hospital stays in Australia

Canadian Substance Use Costs and Harms. Report in Short

LIST OF FIGURES INTRODUCTION

Overview of the Australian National Drug Strategy Household Survey (NDSHS)

COMPUS OPTIMAL THERAPY REPORT. Supporting Informed Decisions. À l appui des décisions éclairées

Legalization and Regulation of Recreational Cannabis PRESENTATION LPPANS NOVEMBER 22, 2017

Addiction Treatment in Canada: The National Treatment Indicators Report

0 questions at random and keep in order

OCSA HEALTH CANADA NOTICE OF INTENT - Vape Products

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

ALCOHOL AND/OR DRUGS AMONG CRASH VICTIMS DYING WITHIN 12 MONTHS OF A CRASH ON A PUBLIC ROAD, BY JURISDICTION: CANADA, 2014

The 2001 Federal Provincial

Legalization of Cannabis: The Way Forward

ONTARIO S STRATEGY TO PREVENT OPIOID ADDICTION AND OVERDOSE. Dr. David Williams Chief Medical Officer of Health

Canadian Organ Replacement Register Annual Report. Treatment of End-Stage Organ Failure in Canada, 2000 to 2009

Health Aging Data Inventory Project

CRYSTAL METH AND OTHER AMPHETAMINES:

January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9

The Impact of Substance Use Disorders on Hospital Use

canadian consortium for gambling research to Discovery Conference 2012 Judith Glynn April 4, 2012

Legalization of non-medical Cannabis OPSBA Update September 08, 2017

C a n a d a. Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD

Are We All Going to Pot?: Legal Issues Arising from Cannabis-Industry Growth The Canadian Perspective

WORKPLACE SMOKING BAN POLICY

Cannabis Legalization August 22, Ministry of Attorney General Ministry of Finance

Student Drug Use in LGL (2009)

OxyContin in the 90 days prior to it being discontinued.

Marijuana in Washington, DC. Arrests, Usage, and Related Data

Canadian Experience in Tobacco Regulations. NCDs Expert Meeting Washington, DC November 17, 2014

A Preliminary Report on Trends and Impact. Mike McGrath. January Montana Attorney General

Ministry of Health and Long-Term Care. Presentation to the CPSO Methadone Prescribers Conference

Cannabis. Introduction. Effects of Cannabis Use. June 2018 Canadian Drug Summary

RE: PROPOSED AMENDMENTS TO REGULATIONS TO THE CONTROLLED DRUGS AND SUBSTANCES ACT

Aussi disponible en français sous le titre : Le Diabète au Canada : Rapport du Système national de surveillance du diabète, 2009

Organization of American States OAS Inter-American Drug Abuse Control Commission CICAD. Multilateral Evaluation Mechanism MEM.

Public Health Association of British Columbia

Drug-related hospital stays in Australia

Macrolides in community-acquired pneumonia and otitis media Canadian Coordinating Office for Health Technology Assessment

Normalizing Conversation, Not Consumption

Trends in adult obesity

Cannabis Legalization and Regulation in British Columbia Discussion Paper

Recent Changes in Cervical Cancer Screening in Canada

4/27/2016. About CCSA. Impaired Driving Research at CCSA. Background. Presentation Overview. Lessons Learned

Canadian Drug Summary: Prescription Opioids

Transcription:

Drug Surveillance Systems in Canada Judy Snider Office of Drugs and Alcohol Research and Surveillance Controlled Substances and Tobacco Directorate Drug Observatories Meeting - CICAD Roseau, Dominica August 4-6, 2009

Federal system: 10 provinces, 3 territories Total Population (2006): 33 million Pop. density: 3.5 persons / sq. km. Territories N=150,000 (0.04%) Atlantic Provinces N=2,328, 831 (7.1%) British Columbia N=4,380,256 (13.3%) Quebec N=7,700,807 (23.3%) Prairie Provinces N= 5,657,532 (17.1%) Ontario N=12,803,861 (38.8%)

Foundation for National Surveillance Strategy: Comprehensive Epidemiological Monitoring System Emphasis upon identifying general and emerging trends in illicit drug use, (including abuse of pharmaceutical products and other substances). Draws on approaches used elsewhere (e.g. IDRS in Australia and DAWN in USA) and existing resources, (e.g. provincial surveys, drug seizure data). Main elements: General population *, student, and high-risk population surveys * Emergency department visits due to alcohol and drugs. Trends analysis of type and composition of drugs seized. * Treatment statistics admissions data. Morbidity and mortality statistics. * Alcohol and pharmaceutical sales. Piloted and continuing in British Columbia. Expanding for national coverage.

Key Resources - data Prevalence and patterns of use: Canadian Alcohol and Drug Use Monitoring Survey (CADUMS) Provincial Epidemiological Monitoring Projects BC & NL Canadian Tobacco Use Monitoring Survey (CTUMS) CAMH Monitor - Centre for Addictions and Mental Health Healthy Behaviours of School-Age Children (HBSC) Survey Youth Smoking Survey (YSS) Enhanced Street Youth Survey (E-SYS) Provincial student drug surveys Treatment data: Provincial (Ont. -DATIS), jurisdictional (BC RHA) Information on seized substances: Controlled Drugs and Substances Database (CSDS) Drug Analysis Service s Laboratory Information Management System (LIMS) Loss and Theft Database Forgeries Database

CADUMS Core Indicators General health and well-being; Smoking (control variable - minimal); Alcohol use & harms (AUDIT); Pharmaceuticals use (use not as indicated; use to get high); Cannabis use & harms (ASSIST & CUDIT); Other illicit drugs use & harms; Alcohol & cannabis use and driving; Pregnancy & substance use; Demographics.

Surveys - Youth in school National Surveys: Youth Smoking Survey in school survey with a main focus on tobacco but alcohol and drug use has been captured since 2002. Health Behaviours of School Aged Children a WHO initiative will be capturing alcohol and drug use data in 2010. Core indicators include: Lifetime use Use in last 12 months Provincial Surveys: e.g., Ontario Student Drug Use and Health Survey (6,000 students in 120 schools) alcohol, drug use and harmful consequences of use since 1977

Multi-method system, launched in British Columbia in 2006; implemented in Newfoundland & Labrador in 2009. Development for expansion to Nova Scotia and Quebec, consisting of the following modules: Provincial analysis of CAS, CADUMS & student drug surveys Regional analysis of illicit drug seizures Statistics on alcohol sales Comprehensive Monitoring System High-risk population surveys: Rave/club/bar patrons. Street-involved youth. Injection drug users. Survey of Emergency Department visits due to alcohol or drugs. Alcohol & drug-related morbidity & mortality analysis Treatment statistics admissions, principal substance... Justice system statistics arrests, convictions.

Drug Analysis Service (DAS) Database Mandate: to conduct chemical analyses of suspected illicit substances for cases proceeding to trial Trends in the types and composition of illicit drugs that are in circulation across the country, including: Prevalence of seized drug samples: National overviews and regional differences. Purity of Samples: Analysis of drug adulterations and cutting agents. Accuracy of identification: What seized substances are suspected to be versus what they actually contain. Limitations

Controlled Drugs and Substances Database (CDSD) CDSD contains comprehensive seizure information (e.g., seizure date, quantity, type and number of seizures) for substances that require authorization under the (Controlled Drugs and Substances Act (CDSA) for destruction. The lag time between seizure and destruction can be 2 to 3 years.

Summary of Drug Situation in Canada The use of illicit drugs in the general population appears to be increasing since the 1990s, although there is evidence of declining prevalence of illicit drug use by youth. The youth rates of use remain higher than the rates of use for adults. The abuse of pharmaceutical products, both prescription drugs and over-the-counter products, is emerging as a significant concern, with prevalence rates exceeding those for some illicit street drugs. Drugs thought to be ecstasy or methamphetamine are increasingly including other drugs and substances. In 2007, the federal government introduced a new National Anti- Drug Strategy (NADS), with increased emphasis and resources for prevention, treatment and enforcement, including a highprofile anti-drug communications strategy. A surveillance strategy is being implemented to better monitor various aspects of the drug situation in Canada.

Contact Information Judy Snider Manager of Surveillance Office of Drugs and Alcohol Research and Surveillance Controlled Substances and Tobacco Directorate Healthy Environments and Consumer Safety Branch Health Canada 123 Slater Street, A.L. 3509C Ottawa ON K1A 1B9 CANADA telephone: (613) 948-2160 E-mail: judy_snider@hc-sc.gc.ca